Gemini Pharmaceuticals competitors

Zippia score 3.9

Gemini Pharmaceuticals main competitors are Interpharm Holdings Inc., Pharmaceutics International, and VistaPharm.

Competitor Summary. See how Gemini Pharmaceuticals compares to its main competitors:

DSM Pharmaceuticals Inc has the most employees (1,200).
Employees at Interpharm Holdings Inc. earn more than most of the competitors, with an average yearly salary of $69,486.

Work at Gemini Pharmaceuticals?

Share your experience

Gemini Pharmaceuticals vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Gemini Pharmaceuticals	-	3.9	Commack, NY	1	$36.4M	100
Nexgen Pharma	1959	4.6	Irvine, CA	1	$50.0M	200
Jarrow Formulas	1977	3.8	Los Angeles, CA	1	$75.0M	50
Contract Pharmacal	1971	4.3	Hauppauge, NY	1	$54.0M	79
Puretek Corporation	-	4.3	San Fernando, CA	1	$20.5M	200
Pharmaceutics International	1994	4.5	Huntingtown, MD	2	$367.8M	1,000
US Pharma Lab	1996	4.5	North Brunswick, NJ	1	$202.0M	150
Tris Pharma	2000	4.2	Monmouth Junction, NJ	1	$102.0M	200
G&W Laboratories	1919	4.7	South Plainfield, NJ	1	$527.2M	300
KVK Tech	2004	4.2	Newtown, PA	1	$1.7M	20
DSM Pharmaceuticals Inc	1993	4.7	Greenville, NC	1	$850.0M	1,200
URL Pharma	1946	4.4	Philadelphia, PA	1	$38.0M	211
Ani Pharmaceuticals	1996	4.4	Baudette, MN	1	$614.4M	601
Mikart	1975	4.1	Atlanta, GA	1	$48.0M	3
Mayne Pharma	-	4.1	Paramus, NJ	1	$780,000	10
Sovereign Pharmaceuticals	1990	4.2	Fort Worth, TX	1	$52.7M	100
Interpharm Holdings Inc.	-	3.9	Hauppauge, NY	1	-	670
VistaPharm	1998	4.2	Largo, FL	1	-	150
STASON PHARMACEUTICALS	1994	3.6	Irvine, CA	1	$1.2M	20
Pharmasol	1973	4.0	Easton, MA	1	$47.3M	69

Rate how well Gemini Pharmaceuticals differentiates itself from its competitors.

Gemini Pharmaceuticals salaries vs competitors

Among Gemini Pharmaceuticals competitors, employees at Interpharm Holdings Inc. earn the most with an average yearly salary of $69,486.

Compare Gemini Pharmaceuticals salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Gemini Pharmaceuticals	$64,879	$31.19	-
Nexgen Pharma	$46,976	$22.58	-
Jarrow Formulas	$64,995	$31.25	-
Contract Pharmacal	$65,761	$31.62	-
Puretek Corporation	$56,341	$27.09	-
Pharmaceutics International	$67,963	$32.67	-

Compare Gemini Pharmaceuticals job title salaries vs competitors

Company	Highest salary	Hourly salary
Gemini Pharmaceuticals	$70,445	$33.87
Tris Pharma	$75,963	$36.52
Pharmaceutics International	$74,054	$35.60
G&W Laboratories	$72,541	$34.88
Puretek Corporation	$72,482	$34.85
URL Pharma	$72,422	$34.82
DSM Pharmaceuticals Inc	$71,560	$34.40
STASON PHARMACEUTICALS	$71,494	$34.37
Interpharm Holdings Inc.	$71,423	$34.34
Mayne Pharma	$71,240	$34.25
KVK Tech	$71,113	$34.19
US Pharma Lab	$70,855	$34.06
Mikart	$70,826	$34.05
Contract Pharmacal	$70,806	$34.04
Ani Pharmaceuticals	$70,754	$34.02
VistaPharm	$70,648	$33.97
Sovereign Pharmaceuticals	$70,587	$33.94
Jarrow Formulas	$70,367	$33.83
Pharmasol	$69,829	$33.57
Nexgen Pharma	$69,529	$33.43

Do you work at Gemini Pharmaceuticals?

Is Gemini Pharmaceuticals able to compete effectively with similar companies?

Gemini Pharmaceuticals jobs

Gemini Pharmaceuticals demographics vs competitors

Compare gender at Gemini Pharmaceuticals vs competitors

Job title	Male	Female
VistaPharm	53%	47%
DSM Pharmaceuticals Inc	54%	46%
Ani Pharmaceuticals	55%	45%
Mayne Pharma	59%	41%
Pharmaceutics International	60%	40%
Gemini Pharmaceuticals	-	-

Male

Female

100%

75%

50%

25%

Gemini Pharmaceuticals

Pharmaceutics International

Mayne Pharma

Ani Pharmaceuticals

DSM Pharmaceuticals Inc

VistaPharm

25%

50%

75%

100%

Compare race at Gemini Pharmaceuticals vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Ani Pharmaceuticals	61%	6%	21%	9%	3%	9.4
DSM Pharmaceuticals Inc	60%	12%	16%	9%	4%	8.9
VistaPharm	43%	25%	13%	16%	3%	6.6
Pharmaceutics International	38%	9%	17%	24%	13%	9.4
Mayne Pharma	50%	33%	8%	5%	3%	7.2
Mikart	50%	16%	22%	9%	3%	8.1

Gemini Pharmaceuticals and similar companies CEOs

CEOBio

Nikhil Lalwani

Ani Pharmaceuticals

Nikhil Lalwani is a Board Member at ANI PHARMACEUTICALS INC and President/CEO at ANI PHARMACEUTICALS INC. He has worked as Chief Executive Officer at Cipla USA Inc.. Nikhil studied at Georgia Tech and The Wharton School.

Matthew Wolf

Contract Pharmacal

Ronald Greenblatt

G&W Laboratories

Aaron Greenblatt is a Chief Executive Officer at G&W Laboratories Inc. He has worked as Director: Business Dev & Sales at G&W Laboratories Inc, Director:Supply Chain at G&W Laboratories Inc, and Chief Commercial Officer at G&W Laboratories Inc. Aaron studied at University of Maryland.

Cameron Reid

Interpharm Holdings Inc.

Cameron Reid is a Board Member at CHEMINOR DRUGS LIMITED and Chief Executive Officer at Interpharm Holdings Inc. He has worked as President at DR. REDDY'S LABORATORIES and Board Member at Interpharm Holdings Inc. Cameron works or has worked as Executive Vice President at Roussel NV. He studied at UCalgary and INSEAD.

Barry Pressman

Puretek Corporation

Barry Pressman is a CEO at Puretek Corporation. He has worked as Pharmacist and manager, co owner at Bi rite Drug Stores and Pharmavite Corporation at Chairman and Co-CEO. Barry studied at William Howard Taft HS between 1955 and 1958 and Brooklyn College of Pharmacy between 1958 and 1962.

Nina Barton

Jarrow Formulas

Nina Barton is a Chief Executive Officer at Natrol and Chief Executive Officer at Jarrow Formulas Inc. She has worked as Chief Growth Officer at KRAFT HEINZ CO, President at KRAFT CANADA INC., and VP:Marketing at KRAFT HEINZ CO. Nina attended McGill University and The Wharton School.

John Fowler

Pharmaceutics International

Scott Richards

Mayne Pharma

Anthony Tabasso

KVK Tech

Mr. Tabasso holds a B.A. from Cornell University, and a J.D. from Villanova University. Prior to joining KVK-Tech, Mr. Tabasso spent 16 years in private practice at a large Philadelphia law firm, where his practice focused on commercial litigation, business restructuring, and transactional work. After serving as outside counsel for many years, Mr. Tabasso joined KVK as President and CEO in August, 2013. Since that time, Mr. Tabasso’s focus has been on committing KVK to three core values: Regulatory Compliance, Safety, and Productivity. Mr. Tabasso has also dedicated KVK to strengthening its commitment to our customers and supply chain partners

Michael Kallelis

Mikart

An entrepreneurial executive specializing in growth strategies. Managing, motivating and coaching people toward a common business goal is a core strength. Experience includes Board of Directors, IPO, M&A, Sales, Business Development, Marketing and Operations. Expertise in start-ups to Fortune 6 environments.Applied growth strategies within the following market segments:In Vitro Diagnostics, Instrument Development, Single-Use bioreactors, Gene Expression Analysis, GMP services, Filtration, Cell Culture, Microscopy, Protein Crystallography, Liquid Chromatography, DNA/RNA chemistry, Peptide chemistry, Biologics, Biosimilars and Drug Development.